URO ONCO

Welcome, this website is intended for all international healthcare professionals in uro-oncology. By clicking the link below you are declaring and confirming that you are a healthcare professional.

You are here

Supporters

URO ONCO is an important source of education and scientific information for many healthcare professionals in uro-oncology. This platform is an initiative from the European Association of Urology, in cooperation with European Urology and Elsevier. It is funded by unrestricted educational grants from pharmaceutical and medical device or equipment companies.

  • Janssen Pharmaceutical Companies of Johnson & Johnson

    The Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving the most important unmet medical needs of our time, including oncology, immunology, neuroscience, infectious disease, and cardiovascular and metabolic diseases.

    Driven by our commitment to patients, Janssen develops innovative products, services and healthcare solutions to help people throughout the world.

    More information can be found at www.janssen-emea.com.

     

     


EAU 2017 Scientific Programme and Sessions

View the Scientific Programme and Sessions of the 2017 EAU Annual Congress, Munich, Germany.

E-Alert

Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

Subscribe

URO ONCO is made possible by an unrestricted educational grant from:

The editorial independence of the resource centre is mandatory and recognized by the EAU and Elsevier.

The journal articles, videos and statements published on the resource centre have been selected independently and without influence from Elsevier, European Urology Editors or the sponsor and do not necessarily reflect their opinions or views.